About
GigaMune develops in vivo cell therapies for cancer and inherited blood disorders by delivering viral gene therapy vectors directly into patients to overcome manufacturing bottlenecks associated with current cell therapies.
Explore GigaMune's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.